USANA Health Sciences, Inc. (USNA)

NYSE: USNA · Real-Time Price · USD

14.43

-0.13 (-0.89%)

At close: Sep 3, 2026, 4:00 PM EDT

14.43

0.00 (0.00%)

After-hours: Sep 3, 2026, 4:20 PM EDT

USANA Health Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Market Capitalization	267	355	680	1,025	1,022	1,970
Market Cap Growth	-54.28%	-47.76%	-33.66%	0.35%	-48.12%	21.43%
Enterprise Value	98	264	315	718	775	1,721
Last Close Price	14.56	19.44	35.69	53.60	53.20	101.20

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
PE Ratio	-	33.03	16.18	16.07	14.73	16.91
Forward PE	14.15	11.17	14.31	19.85	17.05	19.17
PS Ratio	0.29	0.38	0.80	1.11	1.02	1.66
PB Ratio	0.51	0.61	1.16	2.06	2.35	4.99
P/TBV Ratio	0.90	1.36	2.88	2.28	2.66	5.68
P/FCF Ratio	16.57	41.68	13.36	18.26	10.93	18.16
P/OCF Ratio	9.52	15.90	11.15	14.52	9.83	16.25
PEG Ratio	1.19	0.93	1.19	1.65	1.06	1.06

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
EV/Sales Ratio	0.10	0.28	0.37	0.78	0.78	1.45
EV/EBITDA Ratio	1.29	3.16	3.54	6.79	6.40	9.39
EV/EBIT Ratio	2.30	5.18	4.23	7.72	7.20	10.11
EV/FCF Ratio	5.99	30.91	6.19	12.79	8.29	15.87

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Debt / Equity Ratio	-	0.06	0.07	0.03	0.03	0.04
Debt / EBITDA Ratio	-	0.35	0.40	0.12	0.11	0.09
Debt / FCF Ratio	-	3.75	0.77	0.24	0.16	0.16
Net Debt / Equity Ratio	-0.29	-0.22	-0.24	-0.64	-0.63	-0.56
Net Debt / EBITDA Ratio	-2.28	-1.51	-1.60	-3.00	-2.26	-1.22
Net Debt / FCF Ratio	-10.58	-14.83	-2.80	-5.65	-2.93	-2.05
Asset Turnover	1.27	1.24	1.24	1.50	1.70	1.95
Inventory Turnover	2.43	2.33	2.46	2.75	2.34	2.31
Quick Ratio	1.63	1.30	1.36	2.84	2.06	1.54
Current Ratio	2.66	2.24	2.00	3.52	2.67	2.27
Return on Equity (ROE)	-5.06%	1.96%	7.76%	13.69%	16.72%	27.85%
Return on Assets (ROA)	3.61%	4.26%	6.75%	9.46%	11.46%	17.46%
Return on Invested Capital (ROIC)	-112.80%	3.11%	13.17%	34.02%	41.24%	71.77%
Return on Capital Employed (ROCE)	6.90%	8.30%	12.30%	18.10%	23.80%	40.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Earnings Yield	-8.39%	3.03%	6.18%	6.22%	6.79%	5.92%
FCF Yield	6.03%	2.40%	7.49%	5.48%	9.15%	5.51%
Buyback Yield / Dilution	3.10%	3.07%	0.95%	-0.18%	5.08%	4.29%

SEC Filings: 10-K · 10-Q